| Company Name: |
ChemeGen |
| Tel: |
18818260767 |
| Email: |
2625930290@qq.com |
|
| | C22 Glucosylceramide-d4 (d18:1/22:0-d4) Basic information |
| | C22 Glucosylceramide-d4 (d18:1/22:0-d4) Chemical Properties |
| solubility | Chloroform:
Methanol: DI
Water: (2:1:0.1): soluble |
| | C22 Glucosylceramide-d4 (d18:1/22:0-d4) Usage And Synthesis |
| Uses | C22 Glucosylceramide (d18:1/22:0)-d4 is deuterium labeled C22 Glucosylceramide (d18:1/22:0). C22 Glucosylceramide (d18:1/22:0) is an ester product[1]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] BRYAN C BERGMAN. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.[J]. American journal of physiology. Endocrinology and metabolism, 2015, 309 4: E398-408. DOI: 10.1152/ajpendo.00134.2015
[3] MARIONA JOVÉ. Specific Lipidome Signatures in Central Nervous System from Methionine-Restricted Mice[J]. Journal of Proteome Research, 2013, 12 6: 2679-2689. DOI: 10.1021/pr400064a
[4] SZE-MIN EE. Distribution of secretory phospholipase A2 XIIA in the brain and its role in lipid metabolism and cognition.[J]. Molecular Neurobiology, 2014, 50 1: 60-75. DOI: 10.1007/s12035-014-8635-7 |
| | C22 Glucosylceramide-d4 (d18:1/22:0-d4) Preparation Products And Raw materials |
|